Remission InductionRemission, SpontaneousTreatment OutcomeRecurrenceCytarabineAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteCyclophosphamideCombined Modality TherapyVincristinePrecursor Cell Lymphoblastic Leukemia-LymphomaPrednisoneFollow-Up StudiesDaunorubicinPrognosisTransplantation, AutologousPrednisoloneMethotrexateDrug Therapy, CombinationBone Marrow TransplantationTime FactorsDisease-Free SurvivalLeukemia, MyeloidLeukemia, LymphoidDrug Administration ScheduleNeoplasm, ResidualHematopoietic Stem Cell TransplantationNephrotic SyndromeMesalamineSurvival AnalysisAcute DiseaseColitis, UlcerativeTransplantation, HomologousAntirheumatic AgentsDoxorubicinImmunosuppressive AgentsRetrospective StudiesAntineoplastic AgentsAsparaginaseEtoposideAntibodies, Monoclonal, Murine-DerivedSurvival Rate6-MercaptopurineBone MarrowLeukemiaLeukemia, Promyelocytic, AcuteSalvage TherapyThioguanineLymphoma, Non-HodgkinHodgkin DiseaseSeverity of Illness IndexProspective StudiesCrohn DiseaseIdarubicinPituitary ACTH HypersecretionArthritis, RheumatoidAntibodies, MonoclonalDepressive Disorder, MajorLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBleomycinClinical Trials as TopicTransplantation ConditioningWegener GranulomatosisProcarbazineNeoplasm Recurrence, LocalMelphalanCladribineAminosalicylic AcidsActuarial AnalysisGraft vs Host DiseaseVidarabineAzathioprineGastrointestinal AgentsLymphoma, FollicularDisease ProgressionGlomerulonephritis, MembranousMechlorethamineWhole-Body IrradiationAnti-Inflammatory AgentsDouble-Blind MethodSulfasalazineStem Cell TransplantationLeukocyte CountOxidesGlucocorticoidsDrug EvaluationDrug ResistanceMultiple MyelomaAntidepressive AgentsLymphomaBone Marrow PurgingAdrenal Cortex HormonesPulse Therapy, DrugAdministration, OralMyelodysplastic SyndromesCitalopramImmunotherapyPsychiatric Status Rating ScalesImmunologic FactorsBusulfan